HEPHAISTOS-Pharma
HEPHAISTOS-Pharma is an immunotherapies developer for cancer patient founded in 2018.
2
Funding Rounds
$6.8m
Money raised
Funding series
Funding Series Analysis
The company HEPHAISTOS-Pharma has raised a total of $6.8m in funding over 2 rounds.
Key Insights:
- HEPHAISTOS-Pharma May 2024 Seed Funding Round: $4.6m
- HEPHAISTOS-Pharma January 2024 Seed Funding Round: $2.2m
HEPHAISTOS-Pharma May 2024 Seed Funding Round
$4.6m
HEPHAISTOS-Pharma January 2024 Seed Funding Round
$2.2m